Describe tramadol's dual mechanism and a major safety concern.

• A. Weak mu-opioid receptor agonist and SNRI; seizure risk and serotonergic interactions with other meds.
• B. Strong mu-opioid receptor agonist with limited CNS effects.
• C. Delta receptor antagonist with anti-inflammatory properties.
• D. Selective serotonin reuptake inhibitor without opioid activity.

Answer: (A)

Tramadol provides pain relief through two mechanisms: a weak activation of the mu-opioid receptor and inhibition of serotonin and norepinephrine reuptake (an SNRI effect). This dual action explains both its analgesic ability and its safety considerations. The major safety concerns are an increased risk of seizures, especially at higher doses or in people with seizure history, and potential serotonergic interactions with other medications that affect serotonin (such as SSRIs or MAO inhibitors), which can lead to serotonin syndrome. This combination—partial opioid activity plus SNRI activity—best fits tramadol’s pharmacology and the key safety issues, unlike options that describe it as a strong opioid, a delta receptor antagonist, or a pure SSRI without opioid activity.